SlideShare a Scribd company logo
Building Proton Therapy In
China: A Due Diligence Report
Yanfeng Alex Wang
yanfeng12@hotmail.com
May 28, 2016
• How To Build A Proton Therapy Center
• Technology
• What is proton therapy?
• Proton therapy emerges as the latest option to improve
radiotherapy delivery
• Proton therapy overcomes key barriers and becomes commercially
feasible
• Proton therapy centers in U.S.: 23 in operation, 13 in development
or under construction
• Market
• Rapid growth of cancer cases demands increased capacity of
treatment
• China grows fastest in cancer cases
• Proton therapy will cover nine of top ten cancers in China
• Exponential growth of demand on proton therapy
• Projected market size of China: 150 proton therapy centers
• China has two centers in operation
• Finance
• Investment in proton therapy: revenue
• Investment in proton therapy: investment IRR
• Investment in proton therapy: sensitivity test
• Pricing: how much would people pay for proton therapy?
• Price vs. patient throughput: how do they affect investment return?
• How to improve patient throughput?
• Operating margin: a key consideration during negotiation
• Five or one: large center or single unit?
• Human & Organization
• Proton therapy investment: stakeholders analysis
• Proton therapy investment: key hospitals for collaboration --- cancer
specialty hospitals
• Proton therapy investment: key hospitals for collaboration --- top 50
general hospitals
• Case study: a tier-3 city’s ambition to own proton therapy
• Project & Planning
• Proton therapy investment: structure of a possible deal (example)
• Access potential market: how do overseas investors engage in
business development?
• Proton therapy investment: project by phase, risk & solution
• Readiness of proton therapy project
• Appendix: top 50 general hospitals in China
Outline
Outline
Outline
How To Build A Proton Therapy Center
Real Estate
Healthcare
Technology
Investment
Choice of location, approval of land, construction planning and design
Hospital operation, medical staff training, patient referral
Vendor support, equipment installation, image & IT support
Funding resources, investment modeling, transaction/tax advisory
Building proton therapy center requires expertise of multiple dimensions. All those expertise need to be
carefully orchestrated for successful outcomes. In order to build proton therapy center in China, synergy of
resources from both China and United States can facilitate success of investment.
Culture Negotiation, relationship development, risk management
• A frontier radiology technology to treat cancer
• It uses proton beam to kill tumor cells
• It has advantage over conventional radiation, with little damage to
surrounding healthy tissue
• For 30% of all cancer cases, proton therapy has significant advantage
over conventional radiation. For the remaining 70% cases, conventional
radiation works as effectively as proton therapy for now
• Proton therapy was invented in late 1980s. There are 23 proton therapy
centers in U.S. and more to come (refer to “technology: PT centers in
U.S.”)
Technology
What Is Proton Therapy?
• Conventional proton therapy facility needs large construction area of 100,000 square feet. A latest compact version including a single
treatment room uses much less construction area of 2,800 square feet
• Proton therapy center operates like a nuclear plant. Its equipment accelerates proton beam to 2/3 of light speed for treatment. The center
is always built in ground floor and underground like a nuclear bunker, with wall fortification required to block radiation
• Navigated by magnet, photon beam can be guided into up to 5 treatment rooms. Which means the maximum capacity of a center is five
treatment rooms
• Patient will lie still on a treatment bed, while the equipment can be rotated 360 degree in order to orient proton beams to tumor foci. Its
precision can reach 0.5 mm (tumor won’t be totally still because it moves along with breathing and heart beating)
• Among 5 treatment rooms, a popular setup includes 4 rotational and 1 fixed beam room. It reflects breakdown of treatment types,
because some patients won’t need rotational beam
Technology
Proton Therapy Emerges As The Latest Option
To Improve Radiotherapy Delivery
HDRT: high dose radiotherapy
Due to advantage of its
technology (proton vs.
photon), proton therapy
represents the latest trend
of radiotherapy(RT) by
delivering high dose
radiation precisely, to
achieve faster, better, and
safer therapy
Since the technology was invented nearly three decades ago, how come it hasn’t
been popular until recently? There are a few key barriers:
• Debate about advantage of proton therapy over conventional radiotherapy. It’s not
until recent two years when accumulated data show convincing outcomes
• Proton therapy can focus on tumor without radiating surrounding tissue. The
figure on the right compares radiated areas by proton therapy and
conventional radiotherapy in a heat map. Proton therapy can focus on tumor
alone, while conventional radiotherapy affects unintended nearby organs
such as heart
• 30% of all cancer cases can significantly benefit from proton therapy. Doctors
can advise patient whether his/her case should be subject to proton therapy
or conventional radiotherapy
• Scope of investment. Construction of a proton therapy center used to take four
years or longer. Total investment can be $200 million for a 5-treatment room center.
Investors hesitated on large amount of money, long time line, and uncertain buy-in
from patients and providers. Those hurdles can be overcome, which results in
acceleration of investment to new proton therapy centers
• Reimbursement. Medical insurance doesn’t always have a complete coverage of
proton therapy. For example, if conventional radiotherapy receives $2,000
reimbursement, while proton therapy costs $5,000, medical insurance will only
cover $2,000 for proton therapy. The remaining $3,000 will come from patients or
providers. Large patient volume is the key to drive down operating cost. Now
proton therapy is almost on par with conventional radiotherapy if managed properly
Proton Therapy Overcomes Key Barriers
And Becomes Commercially Feasible
Technology
Proton therapy can be less expensive
than surgery and chemotherapy
Technology
PT Centers In United States: 23 In Operation,
13 In Development Or Under Construction
Robert Wood Johnson
Northwestern Medicine
U.Florida Health (UFPTI)
U.Florida Health Cancer
Center Orlando
S Lee Kling, St. Louis
TPTC Provision Healthcare
Ackerman Cancer
Center
Procure, Oklahoma City
Procure, Princeton
Willis Knighton
Cancer Center
Hampton Univ.
Loma Linda (LLUMC)
Maryland MPTC
Mayo Clinic Arizona
Mayo Clinic Rochester
MD Anderson
U. Penn
Scripps, San Diego
SCCA Seattle
Texas Center for PT (Baylor)
Mass General (MGH)
CDH
St. Jude Children’s
Oklahoma Univ.
University Hospital
Georgetown Univ.
Georgia PT (Emory)
Cincinnati Children’s
Beaumont Health
Baptist Health South FL
McLaren Health, Flint New York PT Center
Dallas PT Center (UT Southwestern)
UCSF Ocular
Los Angeles PT Center
Scott Hamilton PT Center
Johns Hopkins Sibly
Center in operation
Center in development
or under construction
Market
Rapid Growth Of Cancer Cases Demands More
Capacity Of Treatment
Cancer ranks No.2 as cause of
death. Aging population and
improved life expectancy result in
rapid growth of cancer cases. By
2030, new cancer cases will be 80%
higher than current level, reaching
25 million per year
• China has 3 to 3.5 million of new cancer cases per year.
Because of its fast aging population (300 million over 65
years old by 2030), by 2030 China will have 5.6 million
new cancer cases a year
• The top three cancer types are lung, stomach, and liver
cancer, which correlates with sustaining social-
environmental health factors such as smoking, air
pollution, diet, and high incidence of hepatitis
Market
China Grows Fastest In Cancer Cases
• Different cancer type has its geographical distribution.
For example, liver cancer incidence is high in southern
coastal provinces where people consume a lot
seafood. Geographical distribution of cancer types will
become a factor when investors choose sites of new
proton therapy centers
• Geographical difference of wealth can implicate
affordability of premium treatment. According to GDP
per capita, coastal provinces and some inland regions
are more likely to pursue premium health technology
than provinces in Midwest
Geographical Distribution Of
Cancer Types
Blue: stomach cancer
Yellow: esophagus cancer
Green: liver cancer GDP Per Capita By Province
Proton therapy has been used to treat 9 out of top 10 most prevalent cancers in China. Liver cancer is the only
exception. Besides cancer, proton therapy has potential to treat other medical conditions.
Market
Proton Therapy Will Cover Nine Of
Top Ten Cancers In China
Market
Exponential Growth Of Demand On Proton
Therapy
A conservative estimate projects 4X growth of number of treatment rooms in 10 years. Purchase of proton therapy equipment
has accelerated since last year. Some PT vendors have reported backlog of orders.
• China has 3.5 million of new diagnosis cancer cases per year. This number will increase to 5.6
million by 2030 due to aging population, equivalent to 3% annual growth
• Between 20% to 30% (average 25%) of cancer cases should be treated by proton therapy: 3.5
million X 25% = 875K cases per year
• Assuming 10% of all patients can afford and would pay for proton therapy: 875K X 10%
= 87.5K cases per year
• Therefore, market size of proton therapy in China is 87.5 thousand cases per year
• If there are 87.5 thousand cases per year, how many proton therapy centers does China
need?
• China needs to build 150 proton therapy centers (or 350 treatment rooms total) to fulfill
demand (refer to finance, table of revenue projection), with 3% annual growth
• Assuming China will take 5 years to build 150 centers (30 per year), and every center costs
$100 million, the nation needs to invest $3 billion per year in proton therapy centers
• Reality check: is China willing to spend $3 billion per year to improve its cancer treatment?
• In 2013, 5.4% GDP or $511.3 billion was spent on healthcare in China. The nation could pay
$6 billion by itself, but would be more willing to attract non-government investment for such
projects
Market
Projected Market Size Of China: 150 Proton
Therapy Centers
3.5 million new
patients per year
Market size: 87.5
thousand patients will
need and can pay for
proton therapy
Market demand:
around 150 proton
therapy centers
In operation
• Wanjie Center, Zibo (Shandong Prov.) has been in operation since 2004. Because
of management and other issues, Wanjie has not fully realized its marketing
potential
• Shanghai Proton and Heavy Ion Center uses technology provided by Siemens, and
is co-managed with Fudan University. It opened in 2014. Because carbon cation
instead of proton is used, strictly speaking it does not belong to proton therapy. The
center is for research, not for commercial purpose
In development or under construction
• Beijing 301 Military Hospital is planning a proton therapy facility (5 treatment
rooms). The center may be designated for privileged citizens due to its military
background. The facility will locate in Zhuozhou (Hebei Prov.), 30 miles southwest
to Beijing. Zhuozhou is chosen because there’s no land in downtown Beijing. The
center will use IBA technology
• Tianjin Cancer Hospital signed a deal, pending for approval. It will use IBA
• Shenyang (Liaoning Prov.) signed a deal, pending for approval. It will use Varian
• Shiyan (Hubei Prov.). The hospital will expand to 3,000 beds, and become a cancer
hospital. It will use Varian
• Guangzhou is planning a 3-room proton therapy center, and expected to open in
late 2018. It will use IBA
Market
China Has Two Centers In Operation
Major vendors:
• Varian (U.S.)
• IBA (Belgium)
• Hitachi (Japan)
Center in operation
Center in development
or under construction
Shenyang
Zhuozhou, Hebei
Tianjin
Weifang, Shandong
Shanghai
Shiyan, Hubei
Guangzhou

More Related Content

Similar to Investing Proton Therapy in China (part)

Radiation Therapy cost in Pune | Cancer Care Pune
Radiation Therapy cost in Pune | Cancer Care PuneRadiation Therapy cost in Pune | Cancer Care Pune
Radiation Therapy cost in Pune | Cancer Care Pune
Jagdish Shinde
 
Radiation Treatment of Rectal and Colon Cancer :: July 2017 #CRCWebinar
Radiation Treatment of Rectal and Colon Cancer :: July 2017 #CRCWebinarRadiation Treatment of Rectal and Colon Cancer :: July 2017 #CRCWebinar
Radiation Treatment of Rectal and Colon Cancer :: July 2017 #CRCWebinar
Fight Colorectal Cancer
 
First of its kind in South India GE IQ PET/CT at MIOT Hospitals
First of its kind in South India GE IQ PET/CT at MIOT HospitalsFirst of its kind in South India GE IQ PET/CT at MIOT Hospitals
First of its kind in South India GE IQ PET/CT at MIOT Hospitals
MIOT Hospitals
 
Radiation treatment dropouts-Pitfalls and solutions: A retrospective observa...
 Radiation treatment dropouts-Pitfalls and solutions: A retrospective observa... Radiation treatment dropouts-Pitfalls and solutions: A retrospective observa...
Radiation treatment dropouts-Pitfalls and solutions: A retrospective observa...
Kanhu Charan
 
Professor Maria Hawkins - UK SABR Service Development Experiences
Professor Maria Hawkins - UK SABR Service Development ExperiencesProfessor Maria Hawkins - UK SABR Service Development Experiences
Professor Maria Hawkins - UK SABR Service Development Experiences
GenesisCareUK
 
Cancer Project in Lao PDR
Cancer Project in Lao PDRCancer Project in Lao PDR
Cancer Project in Lao PDR
Partha_Oncologist
 
Case Study for ARI - Monochromatic X-Rays
Case Study for ARI - Monochromatic X-RaysCase Study for ARI - Monochromatic X-Rays
Case Study for ARI - Monochromatic X-Rays
Aleksey Dubrovensky
 
5-10 (1)
5-10 (1)5-10 (1)
5-10 (1)
Sharon Laver
 
Safety of ct scan.
Safety of ct scan.Safety of ct scan.
Safety of ct scan.
Hisham Aldabagh
 
The State of Lung Cancer Research by Manahil khanam durrani.pptx
The State of Lung Cancer Research by Manahil khanam durrani.pptxThe State of Lung Cancer Research by Manahil khanam durrani.pptx
The State of Lung Cancer Research by Manahil khanam durrani.pptx
The Women University Multan
 
7. Tom Lewis Getting it right for pathology presentation
7. Tom Lewis Getting it right for pathology presentation7. Tom Lewis Getting it right for pathology presentation
7. Tom Lewis Getting it right for pathology presentation
PHEScreening
 
Radiation treatment machine capacity planning at cancer care ontario asli
Radiation treatment machine capacity planning at cancer care ontario asliRadiation treatment machine capacity planning at cancer care ontario asli
Radiation treatment machine capacity planning at cancer care ontario asli
TopanArdiansyah1
 
Certis Oncology Solutons
Certis Oncology SolutonsCertis Oncology Solutons
Certis Oncology Solutons
ArthurHolmes2
 
Apollo Proton Cancer Centre (medical oncology) for Kenyan Patients.pdf
Apollo Proton Cancer Centre (medical oncology) for Kenyan Patients.pdfApollo Proton Cancer Centre (medical oncology) for Kenyan Patients.pdf
Apollo Proton Cancer Centre (medical oncology) for Kenyan Patients.pdf
Apollo Information Centre
 
Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016
Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016
Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016
evadew1
 
About the Ontario Institute for Cancer Research
About the Ontario Institute for Cancer ResearchAbout the Ontario Institute for Cancer Research
About the Ontario Institute for Cancer Research
josephoicr
 
Cancer-Diagnosis-and-Therapy-Congress-17June
Cancer-Diagnosis-and-Therapy-Congress-17JuneCancer-Diagnosis-and-Therapy-Congress-17June
Cancer-Diagnosis-and-Therapy-Congress-17June
Gianni Mura
 
Technology Assessment, Outcomes Research and Economic Analyses
Technology Assessment, Outcomes Research and Economic AnalysesTechnology Assessment, Outcomes Research and Economic Analyses
Technology Assessment, Outcomes Research and Economic Analyses
evadew1
 
Standard of Care - Donna Beardsworth
Standard of Care - Donna BeardsworthStandard of Care - Donna Beardsworth
Standard of Care - Donna Beardsworth
TTC, llc
 
MedicalResearch.com Medical Research News and Interviews September 26 2015
MedicalResearch.com Medical Research News and Interviews September 26 2015MedicalResearch.com Medical Research News and Interviews September 26 2015
MedicalResearch.com Medical Research News and Interviews September 26 2015
Marie Benz
 

Similar to Investing Proton Therapy in China (part) (20)

Radiation Therapy cost in Pune | Cancer Care Pune
Radiation Therapy cost in Pune | Cancer Care PuneRadiation Therapy cost in Pune | Cancer Care Pune
Radiation Therapy cost in Pune | Cancer Care Pune
 
Radiation Treatment of Rectal and Colon Cancer :: July 2017 #CRCWebinar
Radiation Treatment of Rectal and Colon Cancer :: July 2017 #CRCWebinarRadiation Treatment of Rectal and Colon Cancer :: July 2017 #CRCWebinar
Radiation Treatment of Rectal and Colon Cancer :: July 2017 #CRCWebinar
 
First of its kind in South India GE IQ PET/CT at MIOT Hospitals
First of its kind in South India GE IQ PET/CT at MIOT HospitalsFirst of its kind in South India GE IQ PET/CT at MIOT Hospitals
First of its kind in South India GE IQ PET/CT at MIOT Hospitals
 
Radiation treatment dropouts-Pitfalls and solutions: A retrospective observa...
 Radiation treatment dropouts-Pitfalls and solutions: A retrospective observa... Radiation treatment dropouts-Pitfalls and solutions: A retrospective observa...
Radiation treatment dropouts-Pitfalls and solutions: A retrospective observa...
 
Professor Maria Hawkins - UK SABR Service Development Experiences
Professor Maria Hawkins - UK SABR Service Development ExperiencesProfessor Maria Hawkins - UK SABR Service Development Experiences
Professor Maria Hawkins - UK SABR Service Development Experiences
 
Cancer Project in Lao PDR
Cancer Project in Lao PDRCancer Project in Lao PDR
Cancer Project in Lao PDR
 
Case Study for ARI - Monochromatic X-Rays
Case Study for ARI - Monochromatic X-RaysCase Study for ARI - Monochromatic X-Rays
Case Study for ARI - Monochromatic X-Rays
 
5-10 (1)
5-10 (1)5-10 (1)
5-10 (1)
 
Safety of ct scan.
Safety of ct scan.Safety of ct scan.
Safety of ct scan.
 
The State of Lung Cancer Research by Manahil khanam durrani.pptx
The State of Lung Cancer Research by Manahil khanam durrani.pptxThe State of Lung Cancer Research by Manahil khanam durrani.pptx
The State of Lung Cancer Research by Manahil khanam durrani.pptx
 
7. Tom Lewis Getting it right for pathology presentation
7. Tom Lewis Getting it right for pathology presentation7. Tom Lewis Getting it right for pathology presentation
7. Tom Lewis Getting it right for pathology presentation
 
Radiation treatment machine capacity planning at cancer care ontario asli
Radiation treatment machine capacity planning at cancer care ontario asliRadiation treatment machine capacity planning at cancer care ontario asli
Radiation treatment machine capacity planning at cancer care ontario asli
 
Certis Oncology Solutons
Certis Oncology SolutonsCertis Oncology Solutons
Certis Oncology Solutons
 
Apollo Proton Cancer Centre (medical oncology) for Kenyan Patients.pdf
Apollo Proton Cancer Centre (medical oncology) for Kenyan Patients.pdfApollo Proton Cancer Centre (medical oncology) for Kenyan Patients.pdf
Apollo Proton Cancer Centre (medical oncology) for Kenyan Patients.pdf
 
Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016
Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016
Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016
 
About the Ontario Institute for Cancer Research
About the Ontario Institute for Cancer ResearchAbout the Ontario Institute for Cancer Research
About the Ontario Institute for Cancer Research
 
Cancer-Diagnosis-and-Therapy-Congress-17June
Cancer-Diagnosis-and-Therapy-Congress-17JuneCancer-Diagnosis-and-Therapy-Congress-17June
Cancer-Diagnosis-and-Therapy-Congress-17June
 
Technology Assessment, Outcomes Research and Economic Analyses
Technology Assessment, Outcomes Research and Economic AnalysesTechnology Assessment, Outcomes Research and Economic Analyses
Technology Assessment, Outcomes Research and Economic Analyses
 
Standard of Care - Donna Beardsworth
Standard of Care - Donna BeardsworthStandard of Care - Donna Beardsworth
Standard of Care - Donna Beardsworth
 
MedicalResearch.com Medical Research News and Interviews September 26 2015
MedicalResearch.com Medical Research News and Interviews September 26 2015MedicalResearch.com Medical Research News and Interviews September 26 2015
MedicalResearch.com Medical Research News and Interviews September 26 2015
 

Recently uploaded

Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
drhasanrajab
 
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
chandankumarsmartiso
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 

Recently uploaded (20)

Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
 
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 

Investing Proton Therapy in China (part)

  • 1. Building Proton Therapy In China: A Due Diligence Report Yanfeng Alex Wang yanfeng12@hotmail.com May 28, 2016
  • 2. • How To Build A Proton Therapy Center • Technology • What is proton therapy? • Proton therapy emerges as the latest option to improve radiotherapy delivery • Proton therapy overcomes key barriers and becomes commercially feasible • Proton therapy centers in U.S.: 23 in operation, 13 in development or under construction • Market • Rapid growth of cancer cases demands increased capacity of treatment • China grows fastest in cancer cases • Proton therapy will cover nine of top ten cancers in China • Exponential growth of demand on proton therapy • Projected market size of China: 150 proton therapy centers • China has two centers in operation • Finance • Investment in proton therapy: revenue • Investment in proton therapy: investment IRR • Investment in proton therapy: sensitivity test • Pricing: how much would people pay for proton therapy? • Price vs. patient throughput: how do they affect investment return? • How to improve patient throughput? • Operating margin: a key consideration during negotiation • Five or one: large center or single unit? • Human & Organization • Proton therapy investment: stakeholders analysis • Proton therapy investment: key hospitals for collaboration --- cancer specialty hospitals • Proton therapy investment: key hospitals for collaboration --- top 50 general hospitals • Case study: a tier-3 city’s ambition to own proton therapy • Project & Planning • Proton therapy investment: structure of a possible deal (example) • Access potential market: how do overseas investors engage in business development? • Proton therapy investment: project by phase, risk & solution • Readiness of proton therapy project • Appendix: top 50 general hospitals in China Outline Outline
  • 3. Outline How To Build A Proton Therapy Center Real Estate Healthcare Technology Investment Choice of location, approval of land, construction planning and design Hospital operation, medical staff training, patient referral Vendor support, equipment installation, image & IT support Funding resources, investment modeling, transaction/tax advisory Building proton therapy center requires expertise of multiple dimensions. All those expertise need to be carefully orchestrated for successful outcomes. In order to build proton therapy center in China, synergy of resources from both China and United States can facilitate success of investment. Culture Negotiation, relationship development, risk management
  • 4. • A frontier radiology technology to treat cancer • It uses proton beam to kill tumor cells • It has advantage over conventional radiation, with little damage to surrounding healthy tissue • For 30% of all cancer cases, proton therapy has significant advantage over conventional radiation. For the remaining 70% cases, conventional radiation works as effectively as proton therapy for now • Proton therapy was invented in late 1980s. There are 23 proton therapy centers in U.S. and more to come (refer to “technology: PT centers in U.S.”) Technology What Is Proton Therapy? • Conventional proton therapy facility needs large construction area of 100,000 square feet. A latest compact version including a single treatment room uses much less construction area of 2,800 square feet • Proton therapy center operates like a nuclear plant. Its equipment accelerates proton beam to 2/3 of light speed for treatment. The center is always built in ground floor and underground like a nuclear bunker, with wall fortification required to block radiation • Navigated by magnet, photon beam can be guided into up to 5 treatment rooms. Which means the maximum capacity of a center is five treatment rooms • Patient will lie still on a treatment bed, while the equipment can be rotated 360 degree in order to orient proton beams to tumor foci. Its precision can reach 0.5 mm (tumor won’t be totally still because it moves along with breathing and heart beating) • Among 5 treatment rooms, a popular setup includes 4 rotational and 1 fixed beam room. It reflects breakdown of treatment types, because some patients won’t need rotational beam
  • 5. Technology Proton Therapy Emerges As The Latest Option To Improve Radiotherapy Delivery HDRT: high dose radiotherapy Due to advantage of its technology (proton vs. photon), proton therapy represents the latest trend of radiotherapy(RT) by delivering high dose radiation precisely, to achieve faster, better, and safer therapy
  • 6. Since the technology was invented nearly three decades ago, how come it hasn’t been popular until recently? There are a few key barriers: • Debate about advantage of proton therapy over conventional radiotherapy. It’s not until recent two years when accumulated data show convincing outcomes • Proton therapy can focus on tumor without radiating surrounding tissue. The figure on the right compares radiated areas by proton therapy and conventional radiotherapy in a heat map. Proton therapy can focus on tumor alone, while conventional radiotherapy affects unintended nearby organs such as heart • 30% of all cancer cases can significantly benefit from proton therapy. Doctors can advise patient whether his/her case should be subject to proton therapy or conventional radiotherapy • Scope of investment. Construction of a proton therapy center used to take four years or longer. Total investment can be $200 million for a 5-treatment room center. Investors hesitated on large amount of money, long time line, and uncertain buy-in from patients and providers. Those hurdles can be overcome, which results in acceleration of investment to new proton therapy centers • Reimbursement. Medical insurance doesn’t always have a complete coverage of proton therapy. For example, if conventional radiotherapy receives $2,000 reimbursement, while proton therapy costs $5,000, medical insurance will only cover $2,000 for proton therapy. The remaining $3,000 will come from patients or providers. Large patient volume is the key to drive down operating cost. Now proton therapy is almost on par with conventional radiotherapy if managed properly Proton Therapy Overcomes Key Barriers And Becomes Commercially Feasible Technology Proton therapy can be less expensive than surgery and chemotherapy
  • 7. Technology PT Centers In United States: 23 In Operation, 13 In Development Or Under Construction Robert Wood Johnson Northwestern Medicine U.Florida Health (UFPTI) U.Florida Health Cancer Center Orlando S Lee Kling, St. Louis TPTC Provision Healthcare Ackerman Cancer Center Procure, Oklahoma City Procure, Princeton Willis Knighton Cancer Center Hampton Univ. Loma Linda (LLUMC) Maryland MPTC Mayo Clinic Arizona Mayo Clinic Rochester MD Anderson U. Penn Scripps, San Diego SCCA Seattle Texas Center for PT (Baylor) Mass General (MGH) CDH St. Jude Children’s Oklahoma Univ. University Hospital Georgetown Univ. Georgia PT (Emory) Cincinnati Children’s Beaumont Health Baptist Health South FL McLaren Health, Flint New York PT Center Dallas PT Center (UT Southwestern) UCSF Ocular Los Angeles PT Center Scott Hamilton PT Center Johns Hopkins Sibly Center in operation Center in development or under construction
  • 8. Market Rapid Growth Of Cancer Cases Demands More Capacity Of Treatment Cancer ranks No.2 as cause of death. Aging population and improved life expectancy result in rapid growth of cancer cases. By 2030, new cancer cases will be 80% higher than current level, reaching 25 million per year
  • 9. • China has 3 to 3.5 million of new cancer cases per year. Because of its fast aging population (300 million over 65 years old by 2030), by 2030 China will have 5.6 million new cancer cases a year • The top three cancer types are lung, stomach, and liver cancer, which correlates with sustaining social- environmental health factors such as smoking, air pollution, diet, and high incidence of hepatitis Market China Grows Fastest In Cancer Cases • Different cancer type has its geographical distribution. For example, liver cancer incidence is high in southern coastal provinces where people consume a lot seafood. Geographical distribution of cancer types will become a factor when investors choose sites of new proton therapy centers • Geographical difference of wealth can implicate affordability of premium treatment. According to GDP per capita, coastal provinces and some inland regions are more likely to pursue premium health technology than provinces in Midwest Geographical Distribution Of Cancer Types Blue: stomach cancer Yellow: esophagus cancer Green: liver cancer GDP Per Capita By Province
  • 10. Proton therapy has been used to treat 9 out of top 10 most prevalent cancers in China. Liver cancer is the only exception. Besides cancer, proton therapy has potential to treat other medical conditions. Market Proton Therapy Will Cover Nine Of Top Ten Cancers In China
  • 11. Market Exponential Growth Of Demand On Proton Therapy A conservative estimate projects 4X growth of number of treatment rooms in 10 years. Purchase of proton therapy equipment has accelerated since last year. Some PT vendors have reported backlog of orders.
  • 12. • China has 3.5 million of new diagnosis cancer cases per year. This number will increase to 5.6 million by 2030 due to aging population, equivalent to 3% annual growth • Between 20% to 30% (average 25%) of cancer cases should be treated by proton therapy: 3.5 million X 25% = 875K cases per year • Assuming 10% of all patients can afford and would pay for proton therapy: 875K X 10% = 87.5K cases per year • Therefore, market size of proton therapy in China is 87.5 thousand cases per year • If there are 87.5 thousand cases per year, how many proton therapy centers does China need? • China needs to build 150 proton therapy centers (or 350 treatment rooms total) to fulfill demand (refer to finance, table of revenue projection), with 3% annual growth • Assuming China will take 5 years to build 150 centers (30 per year), and every center costs $100 million, the nation needs to invest $3 billion per year in proton therapy centers • Reality check: is China willing to spend $3 billion per year to improve its cancer treatment? • In 2013, 5.4% GDP or $511.3 billion was spent on healthcare in China. The nation could pay $6 billion by itself, but would be more willing to attract non-government investment for such projects Market Projected Market Size Of China: 150 Proton Therapy Centers 3.5 million new patients per year Market size: 87.5 thousand patients will need and can pay for proton therapy Market demand: around 150 proton therapy centers
  • 13. In operation • Wanjie Center, Zibo (Shandong Prov.) has been in operation since 2004. Because of management and other issues, Wanjie has not fully realized its marketing potential • Shanghai Proton and Heavy Ion Center uses technology provided by Siemens, and is co-managed with Fudan University. It opened in 2014. Because carbon cation instead of proton is used, strictly speaking it does not belong to proton therapy. The center is for research, not for commercial purpose In development or under construction • Beijing 301 Military Hospital is planning a proton therapy facility (5 treatment rooms). The center may be designated for privileged citizens due to its military background. The facility will locate in Zhuozhou (Hebei Prov.), 30 miles southwest to Beijing. Zhuozhou is chosen because there’s no land in downtown Beijing. The center will use IBA technology • Tianjin Cancer Hospital signed a deal, pending for approval. It will use IBA • Shenyang (Liaoning Prov.) signed a deal, pending for approval. It will use Varian • Shiyan (Hubei Prov.). The hospital will expand to 3,000 beds, and become a cancer hospital. It will use Varian • Guangzhou is planning a 3-room proton therapy center, and expected to open in late 2018. It will use IBA Market China Has Two Centers In Operation Major vendors: • Varian (U.S.) • IBA (Belgium) • Hitachi (Japan) Center in operation Center in development or under construction Shenyang Zhuozhou, Hebei Tianjin Weifang, Shandong Shanghai Shiyan, Hubei Guangzhou

Editor's Notes

  1. Cancer Types Proton therapy is used for a variety of cancer types, and at Penn Medicine we are constantly working to expand the list of conditions treated with proton therapy. Below are some of the cancers treated with proton therapy: Brain cancer and spinal tumors Breast cancer Gastrointestinal (GI) cancer (colon, esophageal, kidney, pancreatic) Gynecologic (cervical cancer) Head and neck cancer Lung cancer Lymphoma Mesothelioma Pediatric cancer, in conjunction with the Children's Hospital of Philadelphia Prostate cancer Sarcomas http://www.pennprotontherapy.org/cancers-we-treat/
  2. Cancer Types Proton therapy is used for a variety of cancer types, and at Penn Medicine we are constantly working to expand the list of conditions treated with proton therapy. Below are some of the cancers treated with proton therapy: Brain cancer and spinal tumors Breast cancer Gastrointestinal (GI) cancer (colon, esophageal, kidney, pancreatic) Gynecologic (cervical cancer) Head and neck cancer Lung cancer Lymphoma Mesothelioma Pediatric cancer, in conjunction with the Children's Hospital of Philadelphia Prostate cancer Sarcomas http://www.pennprotontherapy.org/cancers-we-treat/
  3. Estimated health care expenditure: $511.3 billion in 2013 Health care as a share of GDP: 5.4 percent in 20131 http://www2.deloitte.com/content/dam/Deloitte/global/Documents/Life-Sciences-Health-Care/gx-lshc-2015-health-care-outlook-china.pdf
  4. http://www2.deloitte.com/content/dam/Deloitte/global/Documents/Life-Sciences-Health-Care/gx-lshc-2015-health-care-outlook-china.pdf